Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 274-977-9 | CAS number: 70880-03-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- Balb/c
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS- Source: Breeding farm VELAZ, Unětice 139, 252 62, Czech Republic (RČH CZ 21760118)- Age at study initiation: 8 - 10 weeks- Weight at study initiation: 18.83 – 20.99 g (at start of dosing), 19.57 – 19.89 g (in pilot experiment)- Housing: monitored conditions, microbiologically defined background, according to internal SOP No.40, animals in groups in macrolon cages with sterilized softwood shavings, cleaning and disinfection of animal room was regularly performed (according to internal SOP No.10)- Diet (e.g. ad libitum): pelleted standard diet for experimental animals ad libitum (Altromin, manufacturer: Altromin Spezialfutter GmbH & Co. KG, Germany) (microbiological control and content of nutrients is performed according internal SOP No. 72)- Water (e.g. ad libitum): drinking tap water ad libitum (water quality corresponded to Regulation No. 252/2004 Czech Coll. Of Law)- Acclimation period: 21 daysENVIRONMENTAL CONDITIONS- Temperature (°C): 22 ± 3 °C (permanently monitored)- Humidity (%): 30 – 70 % (permanently monitored)- Photoperiod (hrs dark / hrs light): 12 hours light/dark cycle
- Vehicle:
- other: DAE 433 (mixture of 40 % dimethylacetamide, 30 % acetone and 30 % ethanol)
- Concentration:
- 75 % w/v(750 mg/mL) 7.5 % w/v(75 mg /mL)0.75 % w/v(7.5 mg /mL)
- No. of animals per dose:
- Pilot experiment: 3 femalesExposed groups: 15 females (5 animals in three groups)Positive control group: 5 femalesNegative control group: 5 femalesTotal: 28 animals
- Details on study design:
- PILOT TEST:The test substance was administered to three animals to assess a possible systemic toxicity or high irritation of skin. One animal per dose group was used in pilot experiment (75, 7.5, 0.75 w/v). Both ears of each mouse was observed for erythema and scored and subsequently ear thickness was measured using digital thickness gauge. Body weight was recorded before application and prior to termination (day 6), MAIN STUDYDay 1 - 3:Open application of 25μL (in the morning, by pipette) of appropriate suspension of the test substance, the vehicle alone or the positive control to the dorsum of each ear.Days 4 - 5:No treatment.Day 6:The weight of animals was recorded. Injection 250 μL of phosphate-buffered saline (PBS) containing 7.76 x10+5 Bq of 3H-methyl thymidine into all test and control mice via the tail vein. Five hours later, the animals were killed. TREATMENT PREPARATION AND ADMINISTRATION:The test substance was administered in the form of suspension in DAE 433 (mixture of 40 % dimethylacetamide, 30 % acetone and 30 % ethanol).The volume of the application form was constant at all groups of animals - 25 µl of the appropriate suspension to the dorsum of each ear once a day morning for 3 consecutive days. The application was performed very slowly by micropipette. Losses caused by draining from the ear must be minimized.The application forms of test substance (suspensions) were prepared immediately before administration.
- Positive control substance(s):
- other: 1-chloro-2,4-dinitrobenzene (CAS: 97-00-7)
- Statistics:
- For statistical calculations the software Statgraphic Centurion (version XV, USA) was used. Statistical evaluation of measured parameters was performed at first by applying the non-parametric Kruskal-Wallis test for testing whether all group samples originate from the same distribution and then the non-parametric two-group Mann-Whitney rank test (probability level 0.05) for two-group comparisons.
- Positive control results:
- see Table 1
- Key result
- Parameter:
- SI
- Value:
- 4.27
- Test group / Remarks:
- 75 %
- Key result
- Parameter:
- SI
- Value:
- 2.96
- Test group / Remarks:
- 7.5 %
- Key result
- Parameter:
- SI
- Value:
- 2.95
- Test group / Remarks:
- 0.75 %
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the given test conditions the animals exposed to the test substance, Reactive Violet 1, elicited sensitising response in LLNA assay. Positive results in cell proliferation revealed that the test substance, Reactive Violet 1, could be a contact allergen in mice. The test substance, Reactive Violet 1, provides positive sensitising response in LLNA assay.
- Executive summary:
The Local Lymph Node Assay (LLNA) with the incorporation of 3H-methyl thymidine radionuclide was used. The testing was conducted according to the Method B.42 – Skin Sensitisation: Local Lymph Node Assay, Council Regulation (EC) No.640/2012, published in O.J. L 193, 2012.
In this study the contact allergenic potential of Reactive Violet 1 was evaluated after topical application to female BALB/c mice. Mice were exposed to three concentrations of test substance suspended in vehicle DAE 433 (mixture of 40 % dimethylacetamide, 30 % acetone and 30 % ethanol) for 3 consecutive days.
In pilot experiment the following concentrations of test substance in application forms were used: 75 %, 7.5 %, 0.75 % (w/v). According to the results of pilot experiment the same doses were confirmed for main study.
Primary proliferation of lymphocytes in the lymph node draining the site of application was evaluated using radioactive labelling of proliferating cells. The ratio of the proliferation in treated groups to that in vehicular controls, termed the Stimulation Index, was determined. The evaluation of ear weight was performed for elimination of false positive findings with certain skin irritants.
Comparison of Stimulation Indexes between treated groups and control vehicle group revealed that the test substance Reactive Violet 1 caused a significant increase in radioisotope incorporation into the DNA of dividing lymphocytes of animals treated by the test substance at all concentrations. The Stimulation Index of the highest treated group is > 3 (75 % - 4.27) and the value of disintegrations per minute (DPM) is significantly increased (at all dose levels) compared to negative control and overall a dose-effect relationship is observed.
The test substance did not cause marked increase of ear weight or other indication of irritation to skin at all dose levels nevertheless statistical significance was observed at the highest and the lowest dose levels. With regard to the Confidential test substance data sheet from Sponsor and no dose-response relationship was not possible that irritation of skin was caused. Residues of the test substance on the ears were visible during whole study so it could cause this weight increase.
The animals exposed to the test substance at all doses showed no pathological and no other negative clinical symptoms of intoxication throughout the experiment.
The positive control item Dinitrochlorobenzene (DNCB) as a contact allergen (concentration 0.5% (w/v) elicited the expected reaction pattern with significant increase in Stimulation Index of cell proliferation and of ear weight. Appropriate performance of the assay in the test laboratory was then demonstrated.
Under the given test conditions, the test substance, Reactive Violet 1, provides positive sensitising response in LLNA assay. The SI at all dose levels was > 3. Dose-response relationship and statistical significance was observed simultaneously.
Reference
Table 1: Individual Activities and Calculated Values
Group | Negative Control | Positive Control | 75% | 7.5% | 0.75% |
Activity (DPM) | 395.79 | 3311.62 | 1201.84 | 836.06 | 922.63 |
290.58 | 2222.54 | 1243.27 | 991.06 | 913.27 | |
254.27 | 3638.39 | 1391.05 | 1054.95 | 820.68 | |
283.01 | 2129.57 | 1371.30 | 941.54 | 1041.75 | |
321.30 | 4009.08 | 1385.73 | 755.17 | 851.74 | |
mean | 308.99 | 3062.24 | 1318.64 | 915.76 | 910.01 |
Standard Deviation | 54.07 | 846.41 | 89.22 | 120.26 | 85.00 |
Stimulation Index | 1.00 | 9.91 | 4.27 | 2.96 | 2.95 |
Table 2: Stimulation Index and ear weight
Group | Radioisotope incorporation | Ear weight | |
Mean DPM | Stimulation Index | Mean (mg) | |
Negative Control | 308.99 | 1.00 | 23.60 |
Positive Control | 3062.24 | 9.91 | 40.14 |
75% | 1318.64 | 4.27 | 25.16 |
7.5% | 915.76 | 2.96 | 24.58 |
0.75% | 910.01 | 2.95 | 24.88 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
In accordance with the LLNA test result, the test substance was classified as skin sensitising category 1B.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.